Structural and physical features that distinguish tumor-controlling from inactive cancer neoepitopes
Proceedings of the National Academy of Sciences · 2023
DOI: 10.1073/pnas.2312057120 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2023. Verfasst von Jean M Custodio und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry and Biochemistry and the Harper Cancer Research Institute, University of Notre Dame, Notre Dame, IN 46556. Hauptthemen laut MEDLINE: Neoplasms. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCATS NIH HHS, NIH HHS, NIGMS NIH HHS.
Abstract (Originalsprache)
Neoepitopes arising from amino acid substitutions due to single nucleotide polymorphisms are targets of T cell immune responses to cancer and are of significant interest in the development of cancer vaccines. However, understanding the characteristics of rare protective neoepitopes that truly control tumor growth has been a challenge, due to their scarcity as well as the challenge of verifying true, neoepitope-dependent tumor control in humans. Taking advantage of recent work in mouse models that circumvented these challenges, here, we compared the structural and physical properties of neoepitopes that range from fully protective to immunologically inactive. As neoepitopes are derived from self-peptides that can induce immune tolerance, we studied not only how the various neoepitopes differ from each other but also from their wild-type counterparts. We identified multiple features associated with protection, including features that describe how neoepitopes differ from self as well as features associated with recognition by diverse T cell receptor repertoires. We demonstrate both the promise and limitations of neoepitope structural analysis and predictive modeling and illustrate important aspects that can be incorporated into neoepitope prediction pipelines.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry and Biochemistry and the Harper Cancer Research Institute, University of Notre Dame, Notre Dame, IN 46556.
- Department of Immunology, and Carole and Ray Neag Comprehensive Cancer Center, University of Connecticut School of Medicine, Farmington, CT 06030.
ORCID-Profile: Tatiana J Rosales, Lauren M Landau, Brian M Baker
Förderung
- NCATS NIH HHS
- NIH HHS
- NIGMS NIH HHS
- HHS | National Institutes of Health
Zitieren
APA
Custodio, J. M., Ayres, C. M., Rosales, T. J., Brambley, C. A., Arbuiso, A. G., Landau, L. M., Keller, G. L. J., Srivastava, P. K., & Baker, B. M. (2023). Structural and physical features that distinguish tumor-controlling from inactive cancer neoepitopes. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2312057120
Vancouver
Custodio JM, Ayres CM, Rosales TJ, Brambley CA, Arbuiso AG, Landau LM, et al. Structural and physical features that distinguish tumor-controlling from inactive cancer neoepitopes. Proceedings of the National Academy of Sciences. 2023. doi:10.1073/pnas.2312057120
BibTeX
@article{Custodio2023,
author = {Custodio, Jean M and Ayres, Cory M and Rosales, Tatiana J and Brambley, Chad A and Arbuiso, Alyssa G and Landau, Lauren M and Keller, Grant L J and Srivastava, Pramod K and Baker, Brian M},
title = {Structural and physical features that distinguish tumor-controlling from inactive cancer neoepitopes},
journal = {Proceedings of the National Academy of Sciences},
year = {2023},
doi = {10.1073/pnas.2312057120}
}
EUVIMED